A Biomarker Study of ATH434 in Participants With MSA
Trial details
- Registry ID
- NCT05864365
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Biomarker Study of ATH434 in Participants With MSANCT05864365 | Alterity Therapeutics | Phase 2 | Completed | 2025-02-26Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |